Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (62) clinical trials

Northern California Research is enrolling participants for a Mild Dementia/Alzheimer's Disease study. The purpose of this study is to see if daily doses of a study medication will improve the symptoms of mild dementia due to Alzheimer's disease. This study medication has been designed to change the cortisol levels in ...

Phase

The purpose of this study is to evaluate Donepezil and Memantine for the treatment of Alzheimer's disease.

Phase

This study is a Phase 2, randomized, placebo controlled, dose ranging study of piromelatine (5, 20, and 50 mg daily for 6 months) versus placebo to determine an effective dose based on efficacy (cognitive performance), safety and tolerability in patients with mild dementia due to AD.

Phase

SPRI Clinical Trials of Brooklyn, under the sponsorship of Suven Life Sciences, is currently participating in the clinical evaluation of the safety and effectiveness of an investigational drug in persons with moderate dementia due to Alzheimer’s disease.

Phase

Patient Inclusion Criteria: Ages: over 60 Male/Female 18 week long Clinical Trial Patient may not be full time permanent resident of nursing home Clinical diagnosis of probable AD with supportive brain imaging documentation Have existing neuropsychiatric symptoms as defined by a score equal or greater than 10 on the NPI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 90 week Long Clinical Trial MMSE score 22-30 Positive amyloid load as indicated by PET assessment Age between 50 and 90 years, inclusive MMSE score equal to or greater than 22, and equal to or less than 30, at Screening and Baseline BMI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 12 Month Long Clinical Trial MMSE score 14-20 Adult patients, 50-90 years of age inclusive at time of screening Probable Alzheimer disease, based on the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS)/Alzheimer's Disease and Related Disorders Association (ADRDA) and DSM-IV-TR ...

Phase

Over 5 million Americans are living with Alzheimer’s. That means millions of families are learning how to cope with this disease. If you or a loved one has been diagnosed with mild to moderate Alzheimer’s, you may be interested in this research study. Clinical Research Associates in Nashville, TN is ...

Phase

Trial of Rifaximin in Probable Alzheimer's Disease

This study aims to improve cognition and function in patients with Alzheimer's Disease (AD) by administering the oral antibiotic, rifaximin. Rifaximin is a virtually non-absorbed antibiotic with the unique properties of altering gut microbiota and lowering blood ammonia levels. It is FDA approved for use in patients with hepatic encephalopathy. ...

Phase

Impact of Nilotinib on Safety Tolerability Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies

A phase II randomized, double blinded, placebo controlled study will be performed to evaluate the impact of Nilotinib (Tasigna, AMN107, Novartis, Switzerland) on safety, tolerability, pharmacokinetics, pharmacodynamics and clinical outcomes in patients with Dementia with Lewy Bodies. Sixty ( 60) participants will be recruited and randomly assigned 1:1 to placebo ...

Phase